Bellon Christine's Form 4 filing
Beam Therapeutics Inc. (BEAM) · filed Jan 20, 2026
- Accession no.
- 0001193125-26-016552
- Filed
- Jan 20, 2026
- Trade date
- Jan 15, 2026
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $644.9K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bellon ChristineCIK 0001963878 | Officer (Chief Legal Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 15, 2026 | Common Stock | SSaleDisposed | −2,111 | $33.62 | −$70,971.82 | 113,556 | Direct | |
| Jan 15, 2026 | Common Stock | SSaleDisposed | −15,959 | $34.72 | −$554,096.48 | 97,597 | Direct | |
| Jan 15, 2026 | Common Stock | SSaleDisposed | −559 | $35.40 | −$19,788.6 | 97,038 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.